Company profile
Ionic Brands Corp.
OTC: IONKF · Healthcare · Drug Manufacturers - Specialty & Generic
#526 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 35
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ market scale, growth stability
Methodology →Revenue TTM
$25.1M
Rev growth YoY (TTM)
+180.4%
Net income (FY)
-$10.9M
Employees
55
as of 2026-08-31
Market cap
$1.6k
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$24.9M$24.9M2021
Net income-$10.9M-$10.9M2021
Operating income-$10.8M-$10.8M2021
Total assets$31.3M$31.3M2021
Liabilities$10.4M$10.4M2021
Equity$20.9M$20.9M2021
Revenue trend
FY2017 – FY2021 · USD
FY17
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Ionic Brands Corp.’s revenue?
Ionic Brands Corp. booked $24.9M in FY2021 revenue, growing 178% year over year — faster than most Healthcare companies we track, at a -43.6% net margin.
Peers · Healthcare
Avant Brands Inc.59CEntrada Therapeutics, Inc.46DMetagenomi, Inc. Common Stock40DHalo Collective Inc.——Precipio, Inc.69BAlumis Inc.35DNeighbors
Pierce →Key facts
CEOBryen Joseph Salas
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersTacoma, WA
ExchangeOTC: IONKF
Employees55
IPO date2017-03-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.